We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Partnership to Offer New Coagulation Testing Solutions Worldwide

By LabMedica International staff writers
Posted on 26 Apr 2015
Print article
Image: In a new collaboration, Abbott will be the exclusive distributor of Sekisui\'s new CP3000 coagulation instrument in various regions, enabling Abbott to provide coagulation testing solutions with the CP3000, a high-throughput system with a compact footprint (Image courtesy of Abbott).
Image: In a new collaboration, Abbott will be the exclusive distributor of Sekisui\'s new CP3000 coagulation instrument in various regions, enabling Abbott to provide coagulation testing solutions with the CP3000, a high-throughput system with a compact footprint (Image courtesy of Abbott).
Abbott (Abbott Park, IL, USA) and Sekisui Diagnostics LLC (Lexington, MA, USA), a sister company of Sekisui Medical (SMD; Tokyo, Japan ), have entered an agreement to offer new coagulation testing solutions for clinical labs to help better assess patient risk of excessive bleeding, developing clots, and other conditions.

Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in various regions, enabling Abbott to provide its coagulation testing solutions with the CP3000, expected to become available later in 2015 in Europe, countries that recognize CE-marking, and non-regulated countries, and in 2016 in the United States. Abbott will have non-exclusive distribution rights with Sekisui in China, Hong Kong, Japan, and Macau.

CP3000 features small sample volume requirement, high-throughput, and a compact footprint. With a broad assay menu and rapid result turnaround time, CP3000 can rapidly meet workflow needs of laboratories of all sizes while providing high quality, reliable results. The system will aim to seamlessly connect to Abbott's “Accelerator a3600” lab automation platform and middleware solution.

"Abbott is committed to providing testing solutions that healthcare providers rely on for actionable information in diagnosing and treating various medical conditions," said Jaime Contreras, senior vice president, Commercial Operations, Diagnostics, Abbott, "Collaborating with Sekisui broadens our offerings within hematology, providing an important component needed to improve care for people around the world." Coagulation testing helps diagnosis blood-related disorders such as hemophilia and thrombosis, and helps clinicians assess patients prior to many medical treatments and in monitoring those who take medications that can affect clotting.

“Coagulation testing has been an important focus for Sekisui for over 20 years," said Robert Schruender, president and chief operating officer of Sekisui Diagnostics, "We are delighted that this relationship with Abbott will bring the benefits of our system, a leading product in Japan, to many customers around the world."

Related Links:

Abbott
Sekisui Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.